Live Breaking News & Updates on Molecular Massively Parallel Simulator

Stay updated with breaking news from Molecular massively parallel simulator. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Molecular Diagnostics Market worth $30.2 billion by 2027 - Exclusive Report by MarketsandMarkets

CHICAGO, May 3, 2022 /PRNewswire/ According to the new market research report "Molecular Diagnostics Market by Product & Service (Reagents, Kits, Instruments), Test Type (Lab, PoC), Technology ....

United States , Kostenloser Wertpapierhandel , Asia Pacific , Aashish Mehra , Technology Immunoassay , Roche Ltd , Product Service Assays , Perkinelmer Inc , Devices Market Research Reports Consulting , Genetics Inc , End User Physician Office , Product Service Instrument , Thermo Fisher Scientific Inc , Product Service Reagents , Research Insight , Test Type Lab , Hologic Inc , Danaher Corporation , Diagnostics Market , Test Type , Genetic Testing , End User , Diagnostic Labs , Sample Pages , North America , Latin America ,

Acquisition adds Key Offerings to Molecular Diagnostics Base

Finnish business Medix Biochemica has broadened its portfolio of molecular diagnostic raw materials for the in vitro diagnostics industry, through the acquisition of myPOLS Biotec which will continue with its operations in Konstanz, Germany. Click to read more. ....

Baden Wüberg , Ramon Kranaster , Medix Biochemica , Steve Ferguson , Medix Biochemica Group , Molecular Diagnostics Business Unit ,

Molecular Targeting Technologies Inc. (MTTI): MTTI and ITM Sign Clinical Supply Agreement for n.c.a. Lutetium-177

Molecular Targeting Technologies Inc. (MTTI), a clinical stage biotech company focused on developing innovative therapies for rare cancers, and ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical ....

Kostenloser Wertpapierhandel , Ben Orzelek , Steffen Schuster , Julia Hofmann Susanne Karlsson , Lu Endolucinbeta , Chris Pak , Molecular Targeting Technologies Inc , Corporate Communications , Molecular Targeting Technologies , Technologies Munich , Targeted Radionuclide Therapy , Targeted Radionuclide Therapies , Radionuclide Therapy , Targeting Technologies , Hofmann Susanne Karlsson ,

Source Photonics Reveals Silicon Photonics 400G DR4 Transceivers for Hyperscale Data Center Networks at OFC 2022

The Silicon-Photonics technology provides a critical path to enable better cost efficiency for high volume manufacturing of 400G transceivers. ....

United States , San Diego , Frank Chang , Source Photonics , Source Photonic , Silicon Photonics , Chief Engineer , Cloud Infrastructure , Physical Sciences , 100 Gigabit Ethernet , And Optical Physics , Small Form Factor Pluggable Transceiver , Terabit Ethernet ,

Molecular Partners, Novartis Say Covid-19 Drug Ensovibep Meets Goals In Phase 2 Study

BASEL (dpa-AFX) - Molecular Partners AG (MOLN) and Novartis announced positive data from phase 2 study for Ensovibep (MP0420), a DARPin Antiviral Therapeutic for COVID-19.A total of 407 patients ....

Antiviral Therapeutic , Molecular Partners ,